Ortho Panel Green Lights VertiFlex’s Superion Spine Spacer

A majority of FDA advisors say the device intended to treat lumbar spinal stenosis has a positive risk-benefit profile but should require an extended postmarket trial to evaluate its safety and efficacy over a longer time period.

More from Archive

More from Medtech Insight